Why is Transgene Biotek falling/rising?

As of 26-Jun, Transgene Biotek Ltd's stock price is currently at 4.51, reflecting an increase of 0.06 or 1.35%. The stock has shown a positive trend, gaining for the last four consecutive days and achieving a return of 5.13% over the past week. Additionally, it has outperformed its sector by 0.58% today. The stock's delivery volume has also seen a significant rise, increasing by 110.36% compared to the 5-day average, indicating heightened investor interest. However, despite these short-term gains, the stock has experienced a substantial decline of 33.97% year-to-date and 48.75% over the past year, suggesting ongoing challenges despite recent positive movements.
In the broader market context, Transgene Biotek's recent performance has outpaced the Sensex, which has only increased by 2.94% over the past week. This indicates that while the stock is experiencing a rebound in the short term, it still faces significant long-term underperformance compared to the benchmark. The stock's moving averages show it is currently above the 5-day, 20-day, 50-day, and 100-day averages, but below the 200-day average, which may suggest a potential for continued upward momentum if it can maintain this positive trend.